We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.27%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$49B
AUM Growth
+$3.11B
(+6.8%)
Cap. Flow
+$228M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
21.37%
Holding
1,104
New
303
Increased
294
Reduced
324
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$282M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$205M |
| 3 |
ConocoPhillips
COP
|
+$203M |
| 4 |
Fortive
FTV
|
+$200M |
| 5 |
Merck
MRK
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$665M |
| 2 |
ExxonMobil
XOM
|
+$332M |
| 3 |
Burlington
BURL
|
+$242M |
| 4 |
National Vision
EYE
|
+$186M |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.67% |
| 2 | Healthcare | 17.99% |
| 3 | Financials | 14.03% |
| 4 | Consumer Discretionary | 11.97% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RPLA
526
DELISTED
Replay Acquisition Corp. Ordinary Shares
RPLA
| $16.7M | 0.03% |
1,750,000
+750,000
| +75% | +$7.61M |
|
|
SCOA
527
DELISTED
ScION Tech Growth I Class A Ordinary Shares
SCOA
| $16.7M | 0.03% |
+1,700,000
| New | +$17.2M |
|
528
Golar LNG
GLNG
$5.19B
| $16.6M | 0.03% |
+1,625,000
| New | +$18.3M |
|
|
JCIC
529
DELISTED
Jack Creek Investment Corp. Class A Ordinary Shares
JCIC
| $16.5M | 0.03% |
+1,700,000
| New | +$16.5M |
|
|
TBA
530
DELISTED
Thoma Bravo Advantage
TBA
| $16.2M | 0.03% |
+1,550,000
| New | +$17.9M |
|
531
Illinois Tool Works
ITW
$84.8B
| $16.2M | 0.03% |
+73,015
| New | +$15.2M |
|
|
CMIIU
532
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
| $16M | 0.03% |
+1,250,000
| New | +$15.7M |
|
533
Raymond James Financial
RJF
$34.5B
| $15.9M | 0.03% |
194,850
-3,900
| -2% | -$291K |
|
534
PENN Entertainment
PENN
$2.69B
| $15.8M | 0.03% |
+150,600
| New | +$16.7M |
|
535
Arista Networks
ANET
$243B
| $15.7M | 0.03% |
834,400
+126,400
| +18% | +$2.36M |
|
536
West Pharmaceutical
WST
$24.5B
| $15.7M | 0.03% |
55,807
-1,500
| -3% | -$429K |
|
|
GHLD
537
DELISTED
Guild Holdings
GHLD
| $15.7M | 0.03% |
1,104,829
+73,929
| +7% | +$1.19M |
|
538
J.M. Smucker
SJM
$12.7B
| $15.7M | 0.03% |
123,727
-2,300
| -2% | -$271K |
|
539
Hewlett Packard
HPE
$69.4B
| $15.6M | 0.03% |
993,836
+368,000
| +59% | +$5.1M |
|
|
CERN
540
DELISTED
Cerner Corp
CERN
| $15.6M | 0.03% |
217,520
-45,600
| -17% | -$3.43M |
|
|
ENNVU
541
DELISTED
ECP Environmental Growth Opportunities Corp. Unit
ENNVU
| $15.6M | 0.03% |
+1,550,000
| New | +$16.2M |
|
542
Protagonist Therapeutics
PTGX
$9.46B
| $15.5M | 0.03% |
600,045
-550,000
| -48% | -$13.9M |
|
543
Pfizer
PFE
$149B
| $15.5M | 0.03% |
+427,801
| New | +$15.2M |
|
544
Pultegroup
PHM
$24.7B
| $15.4M | 0.03% |
294,600
+2,300
| +0.8% | +$107K |
|
545
Broadridge
BR
$18.8B
| $15.4M | 0.03% |
100,900
-22,400
| -18% | -$3.31M |
|
546
EyePoint Inc
EYPT
$1.11B
| $15.4M | 0.03% |
+1,518,211
| New | +$17.1M |
|
547
Bath & Body Works
BBWI
$4.06B
| $15.4M | 0.03% |
307,787
-6,061
| -2% | -$249K |
|
|
GSKY
548
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $15.3M | 0.03% |
2,465,077
-277,510
| -10% | -$1.59M |
|
549
Savara
SVRA
$1.19B
| $15.2M | 0.03% |
7,296,551
+6,896,551
| +1,724% | +$11.8M |
|
550
Alliant Energy
LNT
$18B
| $15.1M | 0.03% |
278,408
+12,218
| +5% | +$608K |
|
Similar funds
Adage Capital Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Adage Capital Partners held 1,104 positions worth $49B, up 6.8% from $45.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners's Q1 2021 filing shows 303 new, 294 increased, 324 reduced and 153 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M. The largest sale was Royalty Pharma, an estimated $665M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q1 2021 buy was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M.
- Adage Capital Partners added most to Alexion Pharmaceuticals in Q1 2021, an estimated $205M increase.
- Adage Capital Partners's biggest Q1 2021 reduction was Royalty Pharma, cutting an estimated $665M.
- Adage Capital Partners fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $175M.
- Adage Capital Partners's ten largest holdings make up 21% of its $49B portfolio in Q1 2021.
- Adage Capital Partners opened 303 new positions and closed 153 in Q1 2021.
- Adage Capital Partners's portfolio value rose 6.8% quarter-over-quarter to $49B.
Based on Adage Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.